North America Menopausal Disorder Treatment Market, By Stages (Menopause, Postmenopause, Perimenopause), Type (Hormonal Therapy and Non-Hormonal Therapy), Menopause Symptoms (Vasomotor Symptoms, Atrophic Vaginitis, Osteoporosis, Joint Pain, Weight Gain, Dyspareunia, Depression, Others), Dosage Form (Tablet, Cream, Gels, Rings/Insert, Patch/Film, Injection Shot, Spray, Others), Route of Administration (Oral, Vaginal, Transdermal, Parenteral), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) – Industry Trends and Forecast to 2030.
North America Menopausal Disorder Treatment Market Analysis and Size
In recent years, the market is projected to grow rapidly during the forecast period 2023-2030. Menopause is tremendously encouraging pharmaceutical companies worldwide to create effective medications to treat it and its associated problems. About 85% of postmenopausal women have experienced a menopausal symptom in their entire lifetime, and the total incidence of vasomotor symptoms alone is anticipated at about 40 to 50 million women in the U.S. Menopausal problems are becoming more and more prevalent all over the world, and numerous healthcare organizations are supporting the development and use of medications that can effectively treat them.
Data Bridge Market Research analyses a growth rate in the menopausal disorder treatment market in the forecast period 2023-2030. The expected CAGR of menopausal disorder treatment market is tend to be around 7.6% in the mentioned forecast period. The market value is USD 5,957.4 million in 2022, and it would grow upto USD 10,704.2 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Menopausal Disorder Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Stages (Menopause, Postmenopause, Perimenopause), Type (Hormonal Therapy and Non-Hormonal Therapy), Menopause Symptoms (Vasomotor Symptoms, Atrophic Vaginitis, Osteoporosis, Joint Pain, Weight Gain, Dyspareunia, Depression, Others), Dosage Form (Tablet, Cream, Gels, Rings/Insert, Patch/Film, Injection Shot, Spray, Others), Route of Administration (Oral, Vaginal, Transdermal, Parenteral), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other)
|
|
Countries Covered
|
U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Belgium
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Abbott (U.S.), Novo Nordisk A/S (Denmark), Abbvie,Inc (U.S.), Dr. Reddy’s Laboratories Ltd. (India), TherapeuticsMD, Inc. (U.S.), Ipsen Pharma (France), Besins Healthcare (Belgium), Mithra Pharmaceuticals (Belgium), Aché Laboratórios Farmacêuticos S.A (Brazil), SEBELA PHARMACEUTICALS (U.S.), Fervent Pharmaceuticals Inc. (U.S.), KaNDy Therapeutics (U.K.), Duchesnay USA (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Menopause is a natural biological process which occurs due to the reduction of reproductive hormones. This marks the end of the menstrual cycle. It usually occurs in the late 40s or 50s. The menopause symptoms occur differently for every women. It has been noticed that the estrogen levels decline throughout menopause. Many women witness symptoms such as night sweats, vaginal dryness, hot flashes while some face abnormal menstrual cycles, difficulty sleeping, mood swings, and others.
North America Menopausal Disorder Treatment Market Dynamics
Drivers
- Increasing Demand of Herbal Treatments
With each passing decade, women are inclining more towards herbal supplements for their menopause treatment which is one of the market's most significant latest developments. As a result, numerous companies are responding to the market need by manufacturing latest products which contain menopause-relieving components. For instance, soy isoflavones and black cohosh are the two natural remedies that work well for menopause. Thus, this new concept is increasing the market growth rapidly.
- Increased Drug Development Processes
An increase in the number of menopausal drugs in the drug development pipeline of several major manufacturers is one of the huge opportunities for the growth of the market. It includes specific and innovative drugs that primarily focus on decreasing side effects and providing improved efficacy. For instance, The first and only body-identical hormone replacement therapy (HRT) for oestrogen insufficiency symptoms in postmenopausal women with an intact uterus and at least a year post their last period, Bijuva, also called as Bijuve in the U.K., which includes estradiol and progesterone in a single daily oral capsule. Thus, this boosts the market growth.
Opportunities
- Major Impact of Trending Lifestyle and Stress
In recent years, it has become positively important to provide women with much effective therapy for menopause symptoms because of the rise in the occurrence of physical and mental health issues among women. Factors such as migraine, anxiety, irritability, formication, fatigue, hot flashes, mood swings, and insomnia led many companies to develop high-end therapies to improve these symptoms. Huge growth in the menopause therapy industry is being aided by widespread investments in extended R&D initiatives to launch novel medications. This factor is helping the market growth in a great way.
- Increasing Demand of Oral Drugs
Oral drugs are one of the easiest, most durable, affordable, and most portable mode of administration. It has been observed that the rate of contamination is also very minimum. This makes this route of administration more beneficial. The oral mode of administration is found to be beneficial especially for the elderly population who suffers from this disorder frequently. Thus, this factor enhances the growth of the market.
Restraints/Challenges
- Growing Underlying Disparities Between Genders
Numerous companies providing multiple treatments for menopause have struggled considerably due to the existence of major gender-wise health disparities in many countries. Women in several countries with limited awareness and income see no gains in their health due to the lack of adequate healthcare infrastructure. This acts as a major restriction for the market.
- Side Effects of Hormone Therapy
According to the FDA, numerous complications associated with hormone therapy carry various hazards, including the possibility of heart problems, stroke, blood clots, and breast cancer. Thus, it hampers the market growth.
This menopausal disorder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the menopausal disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Menopausal disorder Treatment Market
The menopausal disorder treatment market is segmented on the basis of stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Stages
- Menopause
- Postmenopause
- Perimenopause
Type
- Hormonal Therapy
- Non-Hormonal Therapy
Menopause Symptoms
- Vasomotor Symptoms
- Atrophic Vaginitis
- Osteoporosis
- Joint Pain
- Weight Gain
- Dyspareunia
- Depression
- Others
Dosage Form
- Tablet
- Cream
- Gels
- Rings/Insert
- Patch/Film
- Injection Shot
- Spray
- Others
Route of Administration
- Oral
- Vaginal
- Transdermal
- Parenteral
End User
- Hospital/Clinical Laboratories
- Physician Offices
- Reference Laboratories
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Other
North America Menopausal Disorder Treatment Market Regional Analysis/Insights
The menopausal disorder treatment market is analyzed and market size insights and trends are provided by stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel as referenced above.
The major countries covered in the menopausal disorder treatment market report are U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Belgium.
Germany is leading the menopausal disorder treatment market due to the growing demand of many effective treatments such as hormone replacement therapy. Also, the country witnessed advanced medical environment that has resulted in the world's lowest cancer mortality rates, a life expectancy for people over 80 years that is actually more compared to other regions, and minimized heart attack and stroke death rates than those in similar countries. Thus, all these factors led to the market growth in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and North America Menopausal Disorder Treatment Market Share Analysis
The menopausal disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to menopausal disorder treatment market.
Key players operating in the menopausal disorder treatment market include:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France), Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Merck & Co., Inc. (U.S.)
- Eli Lilly and Company (U.S.)
- Abbott (U.S.)
- Novo Nordisk A/S (Denmark)
- Abbvie, Inc (U.S.)
- Dr. Reddy’s Laboratories Ltd. (India)
- TherapeuticsMD, Inc. (U.S.)
- Ipsen Pharma (France)
- Besins Healthcare (Belgium)
- Mithra Pharmaceuticals (Belgium)
- Aché Laboratórios Farmacêuticos S.A (Brazil)
- SEBELA PHARMACEUTICALS (U.S.)
- Fervent Pharmaceuticals Inc. (U.S.)
- KaNDy Therapeutics (U.K.)
- Duchesnay USA (U.S.)
SKU-